Study of dMD-002 for nerve recovery after prostate surgery
Part of Cancer, Kidney & urinary clinical trials.
This study tests a new medication (dMD-002) that may help protect or repair the nerves that control erections during prostate removal surgery. Participating could help improve recovery of erectile function after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer.
- You are scheduled to have your prostate removed with robot-assisted surgery (with or without nerve-sparing).
- You have not had radiation or hormone therapy around the time of surgery.
- You have not had prior prostate surgery (like TURP, laser, or other procedures).
- You have not had a penile implant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special ultrasound tool during prostate cancer surgery helps protect the nerves that control erections. If you have good erectile function and are scheduled for nerve-sparing prostate removal, this trial may be a good fit for you.
This study tests a program to help men follow sexual (erection) rehabilitation after prostate cancer surgery. It may help improve or maintain erectile functioning by supporting the right rehab steps in the months after surgery.
This study tests a new nerve surgery to help men regain erections after prostate cancer surgery. It's for men who have had moderate to severe erectile dysfunction for at least 12 to 18 months after their prostate removal.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This trial tests whether using a special nerve monitor during prostate removal surgery helps preserve the nerves that control erections and bladder control, potentially reducing side effects. If you're scheduled for prostate cancer surgery, this could help improve your recovery.
This trial tests whether a medicine called 4-aminopyridine (4AP) can help recover or protect erectile function after “nerve-sparing” prostate surgery. It’s for men with early-stage, non-spread prostate cancer who are scheduled for robotic prostate surgery and have good baseline erections.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.